Fisetin Prolongs Therapy Window of Brain Ischemic Stroke Using Tissue Plasminogen Activator: A Double-Blind Randomized Placebo-Controlled Clinical Trial

Recombinant tissue plasminogen activator (rt-PA) can be utilized to treat ischemic stroke with safety and effectiveness but limited by a narrow therapeutic window. In the present clinical trial among patients with stroke, we sought to evaluate the potential of fisetin to extend the therapeutic windo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Limin, Cao, Di, Wu, Huijun, Jia, Hongning, Yang, Chaoping, Zhang, Lihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829632/
https://www.ncbi.nlm.nih.gov/pubmed/31434498
http://dx.doi.org/10.1177/1076029619871359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829632/
https://www.ncbi.nlm.nih.gov/pubmed/31434498
http://dx.doi.org/10.1177/1076029619871359

Ejemplares similares